Efficacy and Safety of Mineralocorticoid Receptor Antagonists in Patients with Heart Failure and Chronic Kidney Disease

Mineralocorticoid receptor antagonists (MRA) improve clinical outcomes in patients with heart failure with reduced ejection fraction (HFrEF) and reduce risk of heart failure (HF) hospitalization in patients with heart failure with preserved ejection fraction (HFpEF). However, the benefit and risks o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Cardiol
Autors principals: Khan, Mohammad Saud, Khan, Muhammad Shahzeb, Moustafa, Abdelmoniem, Anderson, Allen S., Mehta, Rupal, Khan, Sadiya S.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7977068/
https://ncbi.nlm.nih.gov/pubmed/31843235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2019.11.014
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars